- Home
- Applications
- arterial hypertension
Refine by
Arterial Hypertension Product Applications
4 applications found
There is a strong evidence with a large cohort, proving that even in the first trimester the increased systolic blood pressure of the aorta and aortic pulse wave velocity (PWVao) could be prognostic marker for later developing pre-eclampsia, which used to occur after 20th week of the gestation. Arteriograph as a reliable method of measuring arterial stiffness could come in handy if used in daily clinical routines to screen those women with higher risk of pre-eclampsia among normotensive ...
ByTensiomed based in Budapest, HUNGARY
Many genetic lung diseases have associated complications involving other organs that, if detected early, can be treated effectively. Early diagnosis is important for preserving lung function. Once a diagnosis of any type of rare lung disease is confirmed, patients will be closely monitored for the development of complications, including lung infection, pneumothorax (collapsed lung), or end-stage lung disease. Earlier diagnosis, leading to earlier initiation of preventative therapies, can improve long-term lung ...
ByTesis Biosciences based in Scottsdale, ARIZONA (USA)
Aortic pulse wave velocity (PWVao) is a powerful independent predictor of mortality in both Diabetes and glucose intolerance test population samples. In displacing systolic blood pressure as a prognostic factor, aortic pulse wave velocity represents a useful integrated index of vascular status and hence cardiovascular diseases. Considering the Diabetes as a vascular disease, the measurement of the aortic stiffness plays an extremely important role in evaluation of the special cardiovascular risk ...
ByTensiomed based in Budapest, HUNGARY
The CV risk assessment and the hypertension management are ones of the most common activities by the cardiologists. The measurement of arterial stiffness provides a strong and independent marker to reveal high CV risk even among those subjects, whose traditional risk factors based CV risk scores provide normal or only intermediate risk. It is a well known fact that there is a significant difference between the anti-hypertensive drugs concerning their lowering ...
ByTensiomed based in Budapest, HUNGARY
